Terms: = Colorectal cancer AND KRAS, C-K-RAS, 3845, P01116, NS3, KI-RAS, KRAS2, K-RAS4A, K-RAS2A, K-RAS4B, KRAS1, K-RAS2B, RASK2 AND Staging
93 results:
1. Association of Fusobacterium nucleatum infection with the clinicopathological characteristics in colorectal cancer patients.
Pang SW; Armon S; Chook JB; Chew J; Peh KB; Lim WW; Peh SC; Teow SY
Mol Biol Rep; 2024 Jan; 51(1):124. PubMed ID: 38227097
[TBL] [Abstract] [Full Text] [Related]
2. Node-negative colon cancer: histological, molecular, and stromal features predicting disease recurrence.
Strous MTA; van der Linden RLA; Gubbels ALHM; Faes TKE; Bosscha K; Bronkhorst CM; Janssen-Heijnen MLG; de Bruïne AP; Vogelaar FJ
Mol Med; 2023 Jun; 29(1):77. PubMed ID: 37344790
[TBL] [Abstract] [Full Text] [Related]
3. Epidemiological and molecular evaluation of BRAF, kras, NRAS genes and MSI in the development of colorectal cancer.
Paula Simedan Vila A; Helena Rodrigues G; Leite Marzochi L; Garcia de Oliveira-Cucolo J; Lívia Silva Galbiatti-Dias A; Felipe Maciel Andrade R; de Santi Neto D; Gomes Netinho J; Castiglioni L; Cristina Pavarino É; Maria Goloni-Bertollo E
Gene; 2023 Jun; 870():147395. PubMed ID: 36990254
[TBL] [Abstract] [Full Text] [Related]
4. Gene Expression Analysis of Immune Regulatory Genes in Circulating Tumour Cells and Peripheral Blood Mononuclear Cells in Patients with colorectal Carcinoma.
Aktar S; Hamid FB; Gamage SMK; Cheng T; Parkneshan N; Lu CT; Islam F; Gopalan V; Lam AK
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902476
[TBL] [Abstract] [Full Text] [Related]
5. Thirty-Year-Old Male Patient with Non-Seminoma and Coincidental Rectal cancer.
Nolting J; Dräger DL; Hakenberg OW; Schneidewind L
Urol Int; 2023; 107(4):429-432. PubMed ID: 36652931
[TBL] [Abstract] [Full Text] [Related]
6. The relationships of OSBPL3 expression with KI-67 expression and kras mutations in CRC: implications for diagnosis and prognosis.
Zhang M; Meng L; Zhang Z; Wu J; Chen X; Wang Y; He J
BMC Med Genomics; 2022 Dec; 15(1):259. PubMed ID: 36517805
[TBL] [Abstract] [Full Text] [Related]
7. Overview of predictive and prognostic biomarkers and their importance in developing a clinical pharmacology treatment plan in colorectal cancer patients.
Crutcher MM; Snook AE; Waldman SA
Expert Rev Clin Pharmacol; 2022 Nov; 15(11):1317-1326. PubMed ID: 36259230
[TBL] [Abstract] [Full Text] [Related]
8. Alarming Drop in Early Stage colorectal cancer Diagnoses After COVID-19 Outbreak: A Real-World Analysis from the Italian COVID-DELAY Study.
Mentrasti G; Cantini L; Zichi C; D'Ostilio N; Gelsomino F; Martinelli E; Chiari R; La Verde N; Bisonni R; Cognigni V; Pinterpe G; Pecci F; Migliore A; Aimar G; De Vita F; Traisci D; Spallanzani A; Martini G; Nicolardi L; Cona MS; Baleani MG; Rocchi MLB; Berardi R
Oncologist; 2022 Sep; 27(9):e723-e730. PubMed ID: 35815922
[TBL] [Abstract] [Full Text] [Related]
9. Prognosis prediction of stage IV colorectal cancer patients by mRNA transcriptional profile.
Wu B; Yang J; Qin Z; Yang H; Shao J; Shang Y
Cancer Med; 2022 Dec; 11(24):4900-4912. PubMed ID: 35587572
[TBL] [Abstract] [Full Text] [Related]
10. HIPK2 Cooperates with kras Signaling and Associates with colorectal cancer Progression.
Di Segni M; Virdia I; Verdina A; Amoreo CA; Baldari S; Toietta G; Diodoro MG; Mottolese M; Sperduti I; Moretti F; Buglioni S; Soddu S; Di Rocco G
Mol Cancer Res; 2022 May; 20(5):686-698. PubMed ID: 35082165
[TBL] [Abstract] [Full Text] [Related]
11. Pathological Features and Prognostication in colorectal cancer.
Chen K; Collins G; Wang H; Toh JWT
Curr Oncol; 2021 Dec; 28(6):5356-5383. PubMed ID: 34940086
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic value of lymphovascular invasion in stage II colorectal cancer patients with an inadequate examination of lymph nodes.
Gao Z; Cao H; Xu X; Wang Q; Wu Y; Lu Q
World J Surg Oncol; 2021 Apr; 19(1):125. PubMed ID: 33866973
[TBL] [Abstract] [Full Text] [Related]
13. Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis.
Zhuang Y; Wang H; Jiang D; Li Y; Feng L; Tian C; Pu M; Wang X; Zhang J; Hu Y; Liu P
BMC Cancer; 2021 Apr; 21(1):380. PubMed ID: 33836681
[TBL] [Abstract] [Full Text] [Related]
14. Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways.
Sihag S; Nussenzweig SC; Walch HS; Hsu M; Tan KS; Sanchez-Vega F; Chatila WK; De La Torre SA; Patel A; Janjigian YY; Maron S; Ku GY; Tang LH; Hechtman J; Shah PM; Wu AJ; Jones DR; Molena D; Solit DB; Schultz N; Berger MF
Clin Cancer Res; 2021 Jun; 27(12):3491-3498. PubMed ID: 33795256
[TBL] [Abstract] [Full Text] [Related]
15. [Update of the recommendations for the determination of biomarkers in colorectal carcinoma. National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology].
Navarro S; Cuatrecasas M; Hernández-Losa J; Landolfi S; Musulén E; Ramón Y Cajal S; García-Carbonero R; García-Foncillas J; Pérez-Segura P; Salazar R; Vera R; García-Alfonso P
Rev Esp Patol; 2021; 54(1):41-54. PubMed ID: 33455693
[TBL] [Abstract] [Full Text] [Related]
16. The Unmet Needs of the Diagnosis, staging, and Treatment of Gastrointestinal Tumors.
Halama N; Haberkorn U
Semin Nucl Med; 2020 Sep; 50(5):389-398. PubMed ID: 32768003
[TBL] [Abstract] [Full Text] [Related]
17. Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
García-Alfonso P; García-Carbonero R; García-Foncillas J; Pérez-Segura P; Salazar R; Vera R; Ramón Y Cajal S; Hernández-Losa J; Landolfi S; Musulén E; Cuatrecasas M; Navarro S
Clin Transl Oncol; 2020 Nov; 22(11):1976-1991. PubMed ID: 32418154
[TBL] [Abstract] [Full Text] [Related]
18. The Impact of kras Mutation on the Presentation and Prognosis of Non-Metastatic Colon cancer: an Analysis from the National cancer Database.
Scott A; Goffredo P; Ginader T; Hrabe J; Gribovskaja-Rupp I; Kapadia MR; Weigel RJ; Hassan I
J Gastrointest Surg; 2020 Jun; 24(6):1402-1410. PubMed ID: 32128676
[TBL] [Abstract] [Full Text] [Related]
19. Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer.
Dienstmann R; Villacampa G; Sveen A; Mason MJ; Niedzwiecki D; Nesbakken A; Moreno V; Warren RS; Lothe RA; Guinney J
Ann Oncol; 2019 Oct; 30(10):1622-1629. PubMed ID: 31504112
[TBL] [Abstract] [Full Text] [Related]
20. External validation of molecular subtype classifications of colorectal cancer based on microsatellite instability, CIMP, BRAF and kras.
Alwers E; Bläker H; Walter V; Jansen L; Kloor M; Arnold A; Sieber-Frank J; Herpel E; Tagscherer KE; Roth W; Chang-Claude J; Brenner H; Hoffmeister M
BMC Cancer; 2019 Jul; 19(1):681. PubMed ID: 31296182
[TBL] [Abstract] [Full Text] [Related]
[Next]
